Avenue Therapeutics, Inc. · OTC:ATXI
Fortress Biotech, Inc. reported a 13.80% stake in Avenue Therapeutics, Inc. (Schedule 13D/A)
Event Dec 31, 2024 · Filed Jan 3, 2025
Fortress Biotech, Inc. reported a 13.80% stake in Avenue Therapeutics, Inc., 295,022 shares, with active intent on Dec 31, 2024. Filed Jan 3, 2025 (Schedule 13D/A).
- Stake
- 13.80%
- Shares
- 295,022
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fortress Biotech, Inc. | 13.80% | 295,022 |
Source
Related
- Avenue Therapeutics, Inc.
- Fortress Biotech, Inc.
- Avenue Therapeutics, Inc. shareholders
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 6, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Apr 2, 2025
- Schedule 13G/A · Ikarian Capital, LLC · Feb 17, 2026
- Schedule 13G · Ikarian Capital, LLC · Feb 14, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025